NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder